Financial Health Assessment: PLASTERLINE LIMITED

1. Financial Health Score: D

Explanation: The business is exhibiting chronic symptoms of financial distress. While it remains operational and maintains positive net assets overall, it has suffered from persistent net current liabilities for multiple consecutive years and a sustained erosion of shareholder equity. The patient is surviving, but its vital signs are concerning and the trajectory is deteriorating.

2. Key Vital Signs

Heartbeat: Liquidity Ratio (Current Ratio)

Reading: Dangerously low. A healthy business typically maintains a current ratio of 1.5:1 or above. At 0.44:1, for every £1 of short-term debts, the company only has 44p of short-term assets to cover it. This is the financial equivalent of shallow, rapid breathing — the business is struggling to meet its immediate obligations from its own resources.

Blood Pressure: Net Current Assets/Liabilities

Reading: Negative working capital has worsened by £3,016 year-on-year. This is not a one-off condition — it has been a persistent feature. The business is chronically overstretched on its short-term obligations.

Weight: Net Assets (Shareholder Equity)

Reading: A clear and concerning downward trend. Shareholder equity has nearly halved in five years, falling from £84,090 to £44,413. This represents accumulated losses eating into the company's reserves — like steady weight loss that signals an underlying condition.

Cholesterol: Leverage (Debt-to-Assets Ratio)

Reading: Elevated and worsening. Over 80p in every £1 of assets is financed by debt. The business is highly leveraged, leaving minimal buffer for downturns.

Bone Density: Fixed Assets

Reading: Fixed assets are declining, suggesting depreciation is outpacing new investment. The business may be running down its productive capacity rather than reinvesting.

3. Diagnosis

Primary Condition: Chronic Working Capital Deficiency

The most critical finding is the persistent net current liability position. The company's current liabilities exceed its current assets by over £134,000. In medical terms, this is like a patient whose outgoings consistently exceed their income — sustainable only with external support (creditor forbearance, director loans, or overdraft facilities).

Secondary Condition: Equity Erosion

The sustained decline in net assets from £84,090 (2021) to £44,413 (2025) confirms the business is trading at a loss or distributing more than it earns. This is a progressive condition — without intervention, the equity base could be exhausted within approximately 5 years at the current rate of attrition.

Complicating Factor: Asset Composition

The company's total assets of £296,674 are heavily weighted toward fixed assets (£190,994 — approximately 64%). While these provide underlying value, fixed assets are illiquid — they cannot easily be converted to cash to pay pressing creditors. The business is asset-rich but cash-poor.

Positive Signs (Immune System)

• Longevity: Over 20 years of trading history suggests resilience and established market position
• Stable workforce: 10 employees maintained year-on-year
• Liabilities slightly reduced: Total liabilities fell from £246,712 to £239,808 (-£6,904)
• Long-term creditors reducing: Fell from £16,379 to £12,453, suggesting debt is being managed
• Still solvent overall: Net assets remain positive at £44,413

4. Recommendations

Immediate Treatment (0-3 months)

1. Cash Flow Triage: Conduct a detailed cash flow forecast to understand the timing of creditor payments. The £239,808 current liabilities need mapping against expected receipts to identify potential payment crises.

2. Creditor Negotiation: Proactively engage key suppliers about extended payment terms. Given the company's 20+ year trading history, this credibility can be leveraged.

3. Debtor Acceleration: Review whether all current assets (likely including debtors) are being collected promptly. Every day of accelerated collection improves the working capital position.

Medium-Term Rehabilitation (3-12 months)

4. Working Capital Restructuring: Consider whether fixed assets can be refinanced. Asset-backed lending against the £190,994 in fixed assets could convert illiquid value into working capital, improving the current ratio.

5. Profitability Review: The consistent equity erosion demands a fundamental review of pricing, cost structure, and margins. The business must return to profitability to arrest the decline.

6. Director Loan Investigation: Determine whether director loans exist within creditors. If so, these could potentially be subordinated or converted to equity to improve the balance sheet presentation.

Long-Term Wellness Plan (12+ months)

7. Growth or Exit Strategy: With net assets declining toward potential insolvency risk, the directors must decide: invest and grow the business back to health, or consider whether a sale or restructuring is more appropriate while equity value remains.

8. Monitoring Regime: Implement quarterly balance sheet reviews with specific targets for current ratio improvement (aim for 1.0:1 within 18 months) and net asset recovery.

Risk Assessment

Prognosis

The business is in a fragile but not terminal condition. The persistent working capital deficiency is the most urgent concern — like a patient with chronic high blood pressure, it can continue for some time but significantly increases the risk of a sudden crisis (e.g., a major creditor demanding payment). The declining equity trend must be arrested within the next 2-3 years, or the business will approach the danger zone of negative net assets. With decisive action on cash flow management, creditor terms, and profitability, recovery is achievable — but the window for corrective action is narrowing.